Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti-inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID-19.
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound / A. Galassi, F. Casanova, L. Gazzola, R. Rinaldo, M. Ceresa, E. Restelli, A. Giorgini, S. Birocchi, M. Giovenzana, U. Zoni, F. Valli, L. Massironi, S. Belletti, L. Magagnoli, A. Stucchi, M. Ippolito, S. Carugo, E. Parazzini, M. Cozzolino. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - (2020 Dec 04). [Epub ahead of print] [10.1002/ccr3.3623]
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound
R. Rinaldo;F. Valli;L. Magagnoli;S. Carugo;M. CozzolinoUltimo
2020
Abstract
Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti-inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID-19.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ccr3.3623.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
3.26 MB
Formato
Adobe PDF
|
3.26 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
